> China and India piggybacking is the least bad thing to happen.
So... the US and European tax- and insurance payers are supposed to pay the billions of dollars for R&D and amortization, just for China to copy everything?
It's bad enough if China does that for their internal market. But they don't stop there, their clones and fakes flood back into our markets as well, leading to regular warnings such as [1] from government authorities for consumer safety.
This is unsustainable on so many levels, it needs to stop.
[1] https://www.swissmedic.ch/swissmedic/de/home/humanarzneimitt...
So we should instead pay so that some companies can do huge profits?
US and European payers aren't paying for neither R&D nor amortization. They're paying a negotiated price that depends mostly on how much value the drug provides to the patient and the health system. The costs for the producers aren't really a factor.